π J&J gains two new lymphoma therapies; Pfizer dumps three drug candidates; US provides draft guidance for decentralised clinical trials
#332 | AstraZeneca takes on asthma in India; Nigeria donβt need no bird flu shots; EU wants to get self-reliant
Hello and welcome back to The Kable for the latest developments in the life sciences industry.
Johnson & Johnson is expanding its presence in the cancer space byΒ acquiring the rights to two next-gen CAR T therapies from Cellular Biomedicines. The two treatments for diffuse large B-cell lymphoma β one in phase 1 testing and the other set to begin human testing this year β are making their way to the pharma giantβs portfolio in a $245 million deal.
Pfizer may have acquired Arena Pharmaceuticals for $6.7 billion in 2021, but now it wants to lighten that load a little bit. Pfizer isΒ dumping three mid-stage medicinesΒ it procured through that acquisition, placing its bets onΒ EtrasimodΒ (currently in development for five diseases) alone.
Incyte, too, is cutting down its R&D pipeline, with 6 discovery programmes β one in anaemia and five in different cancers βΒ going down the drain. The company still has 8 high potential candidates in the pipeline.
Boehringer Ingelheim, meanwhile, is investing overΒ $300 million in a Chemical Innovation Plant at its headquartersΒ to manufacture chemicals and APIs. The facility is expected to be operational by 2026.
The USβsΒ Rockwell Medical is making its way into the UAEΒ with a long-term supply agreement with Global Medical Supply Chain LLC to provide its haemodialysis products.
In the UK, over a million NHS staff are set to receiveΒ a 5% pay hike, putting an end to some of the strikes. But private companies arenβt so lucky;Β 6 of GSKβs manufacturing sites in the UK are being affected by worker strikesΒ β the first wide-ranging strikes in the companyβs history.
The US has releasedΒ draft guidance for the conduct of decentralised clinical trialsΒ for medicines, biologics and medical devices. Decentralised clinical trials imply conducting trial-related activities at sites other than traditional set ups. The hope is that these can reduce the barriers to participation, improving the diversity of trial data and including those with accessibility issues.
Meanwhile, the US FDA has grantedΒ Breakthrough Therapy Designation for the investigational use of Boehringer Ingelheimβs SpesolimabΒ in the prevention of flares in adult patients of generalised pustular psoriasis (GPP).
Another company is issuing a recall due to a labelling error. This time it is TevaΒ recalling 13 batches of its Fentanyl Buccal tabletsΒ used as opioid agonists, indicated for breakthrough pain management in adult cancer patients.
In India,Β AstraZeneca is launching five Centres of ExcellenceΒ as hubs for the treatment and management of severe asthma, hubs which will, in turn, support evolving asthma centres for a systematic approach to diagnosing and treating the condition.
In Thailand, researchers from Chulalongkorn University have developed anΒ MTB strip test kit to diagnose tuberculosis, a disease with severe incidence in the country.
In Korea, theΒ Korea Advanced Institute of Science & Technology has signed MoUs with the USβs Massachusetts General Hospital, Moderna and other partners to improve scientific and medical training and also develop new drugs and vaccines and conduct mRNA research in the country.
We seem to be finally bouncing back from the consequences of the pandemic, with a new WHO report saying thatΒ health systems have started showing the first major signs of recoveryΒ as the delivery of routine health services sees fewer disruptions. But limited availability of health workers, medicines and other resources still plague health delivery in some countries. Continued investments in recovery and resilience are key.
The WHO has also issued aΒ medical product alert concerning the use of valproic acid, or sodium valproate, for the treatment of epilepsy and bipolar disorder in women of childbearing potential. This comes amidst concerns of high risks of birth defects and developmental disorders in children exposed to the substance in the womb.
In Latin America and the Caribbean region,Β PAHO and the AIDS Healthcare Foundation have announced their intention to collaborateΒ on efforts to eliminate HIV/AIDS, TB, viral hepatitis, mpox, and other STIs like syphilis.
In Africa,Β Malawi is set to become the eighth country to ratify the African Medicines Agency treaty, following in Kenyaβs footsteps as it signed the treaty in February this year. All eyes are still on South Africa, the regionβs economic powerhouse, to sign the treaty.
TheΒ Nigeria Sovereign Investment Authority, in the meantime, has launched two flagship companies: NSIA Advanced Medical Service Ltd and Equilease Systems Limited to expand access to quality healthcare services and lease specialised medical equipment, respectively.
In Brazil, the dengue outbreak has seenΒ 6,889 new cases and 6 deathsΒ in the past week.
In Tanzania, an 18-month-old child succumbed to the Marburg virus, taking the countryβsΒ Marburg death toll to 6Β this year.
And finally, in Nigeria, the agriculture and rural development minister is calling for a βno vaccination policyβ for bird flu. Itβs just a waste of money, he claims. Before rushing into vaccine imports, it would be better to conduct activities for virus strain identification, risk assessment and vaccine efficacy testing.Β
Keep reading with a 7-day free trial
Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.